Evolution of surface treatments for the correction of

  • Slides: 10
Download presentation
Evolution of surface treatments for the correction of ametropias PRK FDA approval: 1995 Risk

Evolution of surface treatments for the correction of ametropias PRK FDA approval: 1995 Risk of corneal ectasia Unpredictable flap induced aberrations ADVANCED SURFACE ABLATIONS Epithelial injury Postoperative pain Late visual recovery Risk of Haze LASIK Intrastromal incision In a deep plane FDA approval: 1999 in the stroma

Advanced Surface Ablations The term “advanced surface ablations”: v was coined as a way

Advanced Surface Ablations The term “advanced surface ablations”: v was coined as a way to explain the evolution in surface ablation techniques from the earlier PRK days v covers several techniques such as: v. PRK with the intraoperative use of mitomycin-C (MMC) (PRK-MMC) vepipolis LASIK (Epi-LASIK) vlaser epithelial keratomileusis (LASEK)

Advanced Surface Ablations Advanced surface ablation techniques offer several advantages over conventional PRK such

Advanced Surface Ablations Advanced surface ablation techniques offer several advantages over conventional PRK such as: vincreased quality of vision vreduced postoperative pain vminimized corneal haze

Advanced Surface Ablations Reasons for selecting a surface treatment: v Thin corneas for attempted

Advanced Surface Ablations Reasons for selecting a surface treatment: v Thin corneas for attempted correction (residual bed thickness < 300μm) v Preoperative Dry Eye v Epithelial basement membrane dystrophies v Flat or steep corneas v No risk of flap-related complications v No risk of flap-induced aberrations

Epithelial Removal The epithelium can be removed with several ways: v. Mechanical removal of

Epithelial Removal The epithelium can be removed with several ways: v. Mechanical removal of the epithelium with a blade or newly a rotating brush v. Epithelial removal with the use of alcohol (LASEK) v. Epi-LASIK v. Epithelial removal with the laser (transepithelial)

Evolution of Advanced Surface Ablations (I) v. Introduction of MMC for the control of

Evolution of Advanced Surface Ablations (I) v. Introduction of MMC for the control of corneal haze: v. Therapeutic use globally accepted (selected complicated cases) v. Intraoperative prophylactic use after PRK (PRK-MMC)

Evolution of Advanced Surface Ablations (II) v. Introduction to the retained epithelial flaps (LASEK,

Evolution of Advanced Surface Ablations (II) v. Introduction to the retained epithelial flaps (LASEK, Epi-LASIK): v. Allow for decreased incidence of haze v. Offer with better tolerance of patients v. Mechanical epithelial separation provides with the benefit of avoiding alcohol toxicity

PRK-MMC v 0. 02% for up to 1. 5 min depending on the attempted

PRK-MMC v 0. 02% for up to 1. 5 min depending on the attempted correction (delay in epithelial healing at 2 min) v Reduction of myofibroblast activity / haze (compared to corticosteroids) v Faster visual recovery and confocal microscopic normalization v Safety up to about 10 yrs max experience

LASEK v A dilute solution (20%) is used on the eye in a holding

LASEK v A dilute solution (20%) is used on the eye in a holding cup (8. 5 mm diameter) for approximately 30 seconds in order to loosen the epithelium and creates a complete epithelial flap v After the loosened epithelium is slid to the side and the stromal surface is treated with the laser v The epithelium is replaced or can be directly removed

Epi-LASIK v Surface ablation (epi-polis superficial) v Epithelium is separated as a sheet and

Epi-LASIK v Surface ablation (epi-polis superficial) v Epithelium is separated as a sheet and replaced on the ablated stroma v Special device (Epikeratome) - automated procedure v No use of alcohol v Dealing with drawbacks of PRK (postoperative pain/ discomfort, late visual recovery, haze) and avoiding risks of LASIK v Suitable for thin corneas